Authors


Patrick Buxton, RN, BSN

Latest:

‘The First Role of the Nurse Is Being an Advocate,’ MPN Specialist Says

Nurses treating patients with MPNs should remember to advocate for and empower them.


Karen Hande, PhD, DNP, APRN, ANP-BC, CNE , FAANP, ANEF

Latest:

Recognition of the Advanced Practice Preceptor Role in Oncology

A tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.


Joanna Fawzy Doran, Esq.

Latest:

Discussing Lymphedema Treatment Act, Coverage With Patients

Patients insured by Medicare can now receive coverage for lymphedema compression garments as a result of the Lymphedema Treatment Act, but it is essential that oncology nurses communicate this with their patients.


Jeffrey Bendix

Latest:

CMS Predicts Health Care Spending Will Top $7 Trillion by 2031

It is anticipated that health care spending will grow by an annual average of 5.4% over the next 8 years.


Alexandra M. Hernandez, MSN, APRN, FNP-C

Latest:

Developing a High-Risk Cancer Prevention and Wellness Program to Meet Community Needs

The program’s initiative aims to identify those at increased risk for cancer through assessment and testing and then formulate a personalized evidence-based cancer surveillance or screening plan.


Kathy Burns, MS, APRN-CNS, AGCNS-BC

Latest:

Self-Awareness Is Critical in Treating Prescribing Patients With Cancer and Substance Abuse Disorders

Kathy Burns, MS, APRN-CNS, AGCNS-BC, of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of self-awareness as an oncology nurse when working to overcome one’s implicit bias.


Martin Dietrich, MD, PhD

Latest:

Unmet Needs and Future Directions in the Management of CIM

Martin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.


Grace Choong, MD

Latest:

Grace Choong and Matthew Goetz On the Impact of Adjuvant Endocrine Therapy Omission in ER+ Positive Breast Cancer

Grace Choong, MD; and Matthew Goetz, MD, discuss the effect of omitting adjuvant endocrine therapy for patients with estrogen receptor–positive breast cancer who were treated with neoadjuvant chemotherapy.


Alyson Erardy, LMSW

Latest:

How Mindfulness Can Help Caregivers Cope with Stress and Burnout

Within this intense experience, caregivers can often find themselves physically and emotionally exhausted


Jessica de Paz, BSN, Breast Cancer Survivor

Latest:

Opinion: Post-Mastectomy Chest Numbness: Oncology Nurses Are Key to Patient Education

Oncology nurses are in a unique position to educate patients with breast cancer about post-mastectomy chest numbness.


Maggie Tibbitt

Latest:

Heavily Pretreated Patients With Relapsed/Refractory Myeloma Achieve Encouraging Responses With Teclistamab Plus Daratumumab

An expert with the phase 1b TRIMM-2 trial underscores the significance and findings for patients with multiple myeloma.


AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN

Latest:

AnnMarie Walton on Reducing Antineoplastic Drug Residue in Inpatient Units

AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN, discusses her research on plastic-backed pads and discusses the importance of better methods to reduce exposure to antineoplastic drug residue.


Yolanda A. Coleman, PhD, MS, RN, FACHE, NEA-BC

Latest:

The Evolving Role of the APRN in Oncology Care

The APRN position has an important, albeit recent, history.


Alex Biese

Latest:

Nurses Are “Critical Link” in Providing Patients With Education and Empathy

Oncology nurses provide patients with lung cancer the education and empathy needed to navigate treatment options and adverse event management.


Jonah Feldman

Latest:

Immune Engager Therapies Improve Responses, PFS in RRMM After CAR T-Cell Therapy

Immune engager therapies, according to a retrospective study of real-world patients, had the best rates of responses and progression-free survival in patients with multiple myeloma whose disease relapsed after treatment with idecabtagene vicleucel.


Kyle Doherty

Latest:

Preoperative Systemic Therapy May Improve Survival vs Mastectomy in HER2+ Breast Cancer

Breast-conserving therapy following preoperative systemic therapy resulted in superior overall survival compared with mastectomy in patients with HER2-positive breast cancer.


Nancy C. Long, MSN, AGACNP-BC

Latest:

Caring for a Patient With Relapsed Mantle Cell Lymphoma Undergoing CAR T-Cell Therapy

CAR T-cell therapy represents a viable treatment option for many patients, but there are potentially serious adverse events.


Anaisys Rueda, MSN, APRN-BC

Latest:

Challenges Faced by Adolescent and Young Adult Patients With Cancer

Adolescents and young adults who have cancer also have a negative body image, financial toxicity, and concerns about family planning.


Tiffany Klein, RN, BSN

Latest:

Nurses Hold Power to Change Rhetoric Surrounding Electronic Smoking

Although the long-term effects of e-smoking are still unknown, the percentage of young people developing nicotine dependency is increasing, a Cancer Treatment Centers of America expert explains.


Lindsey Lyle, PA-C, MS

Latest:

Lindsey Lyle on Differentiating MPN Symptoms From Other Health Issues

Lindsey Lyle, PA-C, MS, discusses how oncology nurses can work with their patients to determine if symptoms are related to their myeloproliferative neoplasm or another health condition.


Lisa A. Scholl, MSN, FNP-BC

Latest:

Considerations for Premenopausal Women With TNBC

Triple-negative breast cancer often occurs in women younger than 40.


Michelle Ashley, MSN/MPH, RN, OCN, CBCN, CN-BN, NCTTP

Latest:

Oncology Nurses Can Help Prevent the Preventable

Oncology nurses can play a key role in the prevention of certain cancers.


Denise Myshko

Latest:

Early Trial Suggests that Targeting CLL1-Postive Cells is Effective in Treating Pediatric AML

An early trial evaluated Anti-C-type lectin-like molecule-1 (CLL-1)-based CAR T cells for its safety and efficacy in improving the symptoms of pediatric patients with acute myeloid leukemia (AML).


Chastity M. Washington, MPH, CHES

Latest:

Expert Says Pandemic Put a ‘Lens’ on Health Disparities for People Outside the Medical Field

The director at the Center for Cancer Health Equity, The University of Ohio Comprehensive Cancer Center, discusses how the pandemic put a spotlight on issues of equity within the health care system.



Rebecca Testi, MSN, APN, APN-G

Latest:

Supporting the Patient's Psychosocial Needs Throughout MPN Treatment

Rebecca Testi, MSN, APN, APN-G, from Hackensack Meridian Health, explains ways to help support patients with myeloproliferative neoplasms.


William Goeren, LCSW-R, ACSW, OSW-C, SEP

Latest:

Cancer, COVID-19, and Aging in LGBTQ+ Communities

The reasons for LGBTQ+ health care disparities are complex but unequivocal, founded in many socio-economic and cultural factors.


Meghan K. Berkenstock, MD

Latest:

Meghan Berkenstock on Managing Ocular Toxicities With ADCs in Cervical and Ovarian Cancers

Meghan K. Berkenstock, MD, discusses the growing need for strong collaboration between ophthalmologists and gynecologic oncology care teams.


Sue Stephens, MSW, LCSW, ACSW

Latest:

Collaboration Between Pediatric Oncology Nurses and Social Workers Decreases Treatment-Related Distress

Pediatric oncology nurses and social workers routinely collaborate not only in the biopsychosocial assessment of families’ psychosocial needs and distress, but in developing interventions that can improve a patient’s and family’s quality of life while in pediatric cancer treatment and in survivorship.


Yelena Shames, MSA, ACNP-BC, CNRN

Latest:

Yelena Shames on Pausing Immunotherapy for Laboratory Abnormalities

Yelena Shames, MSA, ACNP-BC, CNRN, discusses when immune checkpoint inhibitor treatment should be paused because of laboratory abnormalities.

© 2024 MJH Life Sciences

All rights reserved.